Racialized risk environments in a large sample of people who inject drugs in the United States

International Journal of Drug Policy

Volumn 27, Issue , 2016, Pages 43-55

  Cooper, Hannah L F ^a   Linton, Sabriya ^a   Kelley, Mary E ^a   Ross, Zev ^b   Wolfe, Mary E ^a   Chen, Yen Tyng ^a   Zlotorzynska, Maria ^a   Hunter Jones, Josalin ^a   Friedman, Samuel R ^c   Des Jarlais, Don ^d   Semaan, Salaam ^e   Tempalski, Barbara ^c   DiNenno, Elizabeth ^e   Broz, Dita ^e   Wejnert, Cyprian ^e   Paz Bailey, Gabriela ^e   Taussig, Jennifer ^f   Johnson, Shacara ^f   Todd, Jeff ^f   Flynn, Colin ^f   German, Danielle ^f   Isenberg, Debbie ^f   Driscoll, Maura ^f   Hurwitz, Elizabeth ^f   Prachand, Nikhil ^f   Benbow, Nanette ^f   Melville, Sharon ^f   Yeager, Richard ^f   Dyer, Jim ^f   Novoa, Alicia ^f   Thrun, Mark ^f   Al Tayyib, Alia ^f   Higgins, Emily ^f   Mokotoff, Eve ^f   Griffin, Vivian ^f   Sayegh, Aaron ^f   Risser, Jan ^f   Rehman, Hafeez ^f   Bingham, Trista ^f   Sey, Ekow Kwa ^f   Metsch, Lisa ^f   Forrest, David ^f   Beck, Dano ^f   Cardenas, Gabriel ^f   Nemeth, Chris ^g   Smith, Lou ^g   Watson, Carol Ann ^g   Robinson, William ^f   Gruber, DeAnn ^f   Barak, Narquis ^f   Neaigus, Alan ^f   Jenness, Samuel ^f   Wendel, Travis ^f   Gelpi Acosta, Camila ^f   Hagan, Holly ^f   Godette, Henry ^f   Bolden, Barbara ^f   D'Errico, Sally ^f   Brady, Kathleen ^f   Kirkland, Althea ^f   Shpaner, Mark ^f   Miguelino Keasling, Vanessa ^f   Velasco, Al ^f   Raymond, H Fisher ^f   De León, Sandra Miranda ^h   Rolón Coloón, Yadira ^f   Courogen, Maria ^f   Thiede, Hanne ^f   Burt, Richard ^f   Herbert, Michael ^f   Friedberg, Yelena ^f   Wrigley, Dale ^f   Fisher, Jacob ^f   Sansone, Marie ^f   West Ojo, Tiffany ^f   Magnus, Manya ^f   Kuo, Irene ^f   more..

^a EMORY UNIVERSITY   (United States)

^b ZevRoss Spatial   (United States)

^c NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f NONE   (United States)

^g Nassau Suffolk   (United States)

^h Hospital Municipal de San Juan   (Puerto Rico)

Author keywords

Critical race theory; HIV; Injection drug use; National HIV Behavioral Surveillance; Residence characteristics; Risk environments

Indexed keywords

ADULT; AFRICAN AMERICAN; CAUCASIAN; ENVIRONMENT; ETHNOLOGY; FEMALE; HEALTH DISPARITY; HISPANIC; HIV INFECTIONS; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; RISK; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; UNITED STATES;

ADULT; AFRICAN AMERICANS; DATA COLLECTION; ENVIRONMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 84954364806     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.07.015     Document Type: Article

References (94)

1. Alexander M. The New Jim Crow: Mass incarceration in the age of colorblindness 2010, New Press, New York/Jackson, TN, (Distributed by Perseus Distribution).
2. Allard S. Access to social services: The changing urban geography of poverty and service provision. Metropolitan policy program survey series 2004, The Brookings Institution, Washington, DC.
3. Bailey T.C., Gastrell A.C. Interactive spatial data analysis 1995, Longman Scientific and Technical, Essex, England.
4. Beardsley K., Wish E., Fitzelle D., O'Grady K.E., Arria A. Distance traveled to outpatient drugtreatment and client retention and client retention. Journal of Substance Abuse Treatment 2003, 25(4):279-285.
5. Biello K.B., Kershaw T., Nelson R., Hogben M., Ickovics J., Niccolai L.M. Racial residential segregation and rates of gonorrhea in the United States, 2003-2007. American Journal of Public Health 2012, 102(7):1370-1377.
6. Bleich S.N., Thorpe R.J., Sharif-Harris H., Fesahazion R., Laveist T.A. Social context explains race disparities in obesity among women. Journal of Epidemiology & Community Health 2010, 64(5):465-469.
7. Bonilla-Silva E. White supremacy and racism in the post-civil rights era 2001, Lynne Rienner Publishers.
8. Broz D., Wejnert C., Pham H.T., DiNenno E., Heffelfinger J.D., Cribbin M., et al. HIV infection and risk, prevention, and testing behaviors among injecting drug users - National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. MMWR Surveillance Summaries 2014, 63(6):1-51.
9. Burris S., Anderson E.D., Craigg A., Davis C., Case P. Racial disparities in injection-related HIV: A case study of toxic law. Temple Law Review 2010, Spring/Summer:1-51.
10. Centers for Disease Control and Prevention Racial/ethnic disparities in diagnoses of HIV/AIDS - 33 states, 2001-2004. MMWR 2006, 55(5):121-125.
11. Centers for Disease Control and Prevention Strategic plan: The division of HIV/AIDS prevention 2011 through 2015 2011, CDC, Atlanta, GA.
12. Centers for Disease Control and Prevention Diagnoses of HIV infection among adults and adolescents, by sex and transmission category, 2010 - 46 states and 5 U.S. dependent areas. HIV surveillance report 2012, 22. CDC, Atlanta, GA.
13. Centers for Disease Control and Prevention HIV infection and HIV-associated behaviors among injecting drug users - 20 cities. United States, 2009. MMWR 2012, 61(8):133-138.
14. Centers for Disease Control and Prevention Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recommendations & Reports 2012, 61(RR-5):1-40.
15. Centers for Disease Control and Prevention Expanded Testing Initiative 2013 April, Retrieved from http://www.cdc.gov/hiv/policies/eti.html.
16. Cohen D.A., Ghosh-Dastidar B., Scribner R., Miu A., Scott M., Robinson P., et al. Alcohol outlets, gonorrhea, and the Los Angeles civil unrest: A longitudinal analysis. Social Science and Medicine 2006, 62:3062-3071.
17. Cooper H., Bossak B., Tempalski B., Friedman S., Des Jarlais D. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: Relationship to local racial/ethnic composition and need. Journal of Urban Health 2009, 86(6):929-945.
18. Cooper H., Des Jarlais D.C., Ross Z., Tempalski B., Bossak B., Friedman S.R. Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes. American Journal of Public Health 2011, 101(6):1118-1125.
19. Cooper H., Des Jarlais D.C., Ross Z., Tempalski B., Bossak B., Friedman S.R. Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: A longitudinal multilevel study. Journal of Urban Health 2012, 89(4):678-696.
20. Cooper H., Friedman S.R., Tempalski B., Friedman R. Residential segregation and the prevalence of injection drug use among black adult residents of US metropolitan areas. American Journal of Public Health 2007, 97(2):344-352.
21. Cooper H., Moore L., Gruskin S., Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science & Medicine 2005, 61(3):673-684.
22. Cooper H.L. Medical theories of opiate addiction's aetiology and their relationship to addicts' perceived social position in the United States: An historical analysis. International Journal of Drug Policy 2004, 15(5-6):435-445.
23. Cooper H.L., Bossak B.H., Tempalski B., Des Jarlais D.C., Friedman S.R. Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy 2008, 20:217-226.
24. Cooper H.L., Des Jarlais D.C., Tempalski B., Bossak B.H., Ross Z., Friedman S.R. Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: Combined effects on the risk of injection-related infections among injectors. Health & Place 2012, 18(2):218-228.
25. Cooper H.L., Wypij D., Krieger N. Police drug crackdowns and hospitalization rates for illicit-injection-related infections in New York City. International Journal of Drug Policy 2005, 16:150-160.
26. Courtwright D. Dark paradise: A history of opiate addiction in America 2001, Harvard University Press, Cambridge, MA.
27. Dawkins C. Recent evidence on the continuing causes of Black-White residential segregation. Journal of Urban Affairs 2004, 26(3):379-400.
28. Degenhardt L., Mathers B., Vickerman P., Rhodes T., Latkin C., Hickman M. Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed. Lancet 2010, 376(9737):285-301.
29. Deren S., Gelpí-Acosta C., Albizu-García C., González A., Des Jarlais D.C., Santiago-Negrón S. Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: The need for a multiregion approach. American Journal of Public Health 2014, 104(11):2030-2036.
30. Des Jarlais D.C., Cooper H.L.F., Bramson H., Deren S., Hatzakis A., Hagan H. Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs. Current Opinion in HIV & AIDS 2012, 7(4):354-361.
31. Do D.P., Finch B.K., Basurto-Davila R., Bird C., Escarce J., Lurie N. Does place explain racial health disparities? Quantifying the contribution of residential context to the Black/white health gap in the United States. Social Science & Medicine 2008, 67(8):1258-1268.
32. Fortney J., Rost K., Warren J. Comparing alternative methods of measuring geographic access to health services. Health Services & Outcomes Research Methodology 2000, 1(2):173-184.
33. Frey W. Melting pot cities and suburbs: Racial and ethnic change in Metro America in the 2000s. Metropolitan policy program at Brookings 2011, The Brookings Institute, Washington, DC.
34. Friedman S., Cooper H., Tempalski B., Keem M., Friedman R., Flom P., et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006, 20(1):93-99.
35. Friedman S.R., Cooper H.L.F., Osborne A.H. Structural and social contexts of HIV risk among African Americans [Erratum appears in American Journal of Public Health, 2009 Aug;99(8):1352]. American Journal of Public Health 2009, 99(6):1002-1008.
36. Friedman S.R., Perlis T., Des Jarlais D.C. Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health 2001, 91(5):791-793.
37. Friedman S.R., Quimby E., Sufian M., Abdul-Quader A., Des Jarlais D.C. Network and sociohistorical approaches to the HIV epidemic among drug injectors. The impact of AIDS: Psychological and social aspects of HIV infection 1997, 89-113. Harwood Academic Publishers, Amsterdam, The Netherlands. J. Catalan, L. Sherr, B. Hedge (Eds.).
38. Friedman S.R., Young P.A., Snyder F.R., Shorty V., Jones A., Estrada A.L., et al. Racial differences in sexual behaviors related to AIDS in a nineteen city sample of street-recruited drug injectors. AIDS Education and Prevention 1993, 5(3):196-211.
39. Gallagher K., Sullivan P.S., Lansky A., Onorato I. Behavioral surveillance among people at risk for HIV infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Reports 2007, 122(Suppl. 1):32-38.
40. Goldenberg S.M., Strathdee S.A., Gallardo M., Rhodes T., Wagner K.D., Patterson T.L. "Over here, it's just drugs, women and all the madness": The HIV risk environment of clients of female sex workers in Tijuana, Mexico. Social Science & Medicine 2011, 72(7):1185-1192.
41. Greenberg J. Report on Roma education today: From slavery to segregation and beyond. Columbia Law Review 2010, 110(4):919-1001.
42. Grigoryan A., Hall H.I., Durant T., Wei X. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS ONE 2009, 4(2):e4445. (Electronic resource).
43. Hallinan M.T. Classroom racial composition and children's friendships. Social Forces 1982, 61(1):56-72.
44. Haynes K.E., Fotheringhan A.S. Gravity and spatial interaction models 1984, Sage Publications, Beverly Hills, CA.
45. Hennekens C.H., Buring J.E. Epidemiology in medicine 1987, Little Brown and Company, Boston, MA.
46. Hwang H.-L., Rollow J. Data processing procedures and methodology for estimating trip distances for the 1995 American Travel Survey (ATS) 2000, Oak Ridge National Laboratory, Oak Ridge, TN.
47. Idler E., Kasl S.V. Health perceptions and survival: Do global evaluations of health status really predict mortality?. Journal of Gerontology: Social Sciences 1991, 46(2):S55-S65.
48. Idler E.L., Benyamini Y. Self-rated health and mortality: A review of twenty-seven community studies. Journal of Health & Social Behavior 1997, 38(1):21-37.
49. Idler E.L., Russell L.B., Davis D. Survival, functional limitations, and self-rated health in the NHANES I Epidemiologic Follow-up Study, 1992. First National Health and Nutrition Examination Survey. American Journal of Epidemiology 2000, 152(9):874-883.
50. Jacoby I. Geographic distribution of physician manpower: The GMENAC (Graduate Medical Education National Advisory Committee) legacy. Journal of Rural Health 1991, 7(4 (Suppl.)):427-436.
51. Joassart-Marcelli P. Leveling the playing field? Urban disparities in funding for local parks and recreation in the Los Angeles region. Environment and Planning A 2010, 42(5):1174-1192.
52. Keppel K., Pamuk E., Lynch J. Methodological issues in measuring health disparities. Vital and health statistics 2005, 2. National Center for Health Statistics, Bethesda, MD.
53. Kottiri B., Friedman S., Neaigus A., Curtis R., Des Jarlais D. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. JAIDS 2002, 30(1):95-104.
54. Kral A.H., Malekinejad M., Vaudrey J., Martinez A.N., Lorvick J., McFarland W., et al. Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco. Journal of Urban Health 2010, 87(5):839-850.
55. Kramer M.R., Hogue C.R. Is segregation bad for your health?. Epidemiologic Reviews 2009, 31:178-194.
56. Laffoon B., Satcher Johnson A., Cohen S., Hu X., Shouse R. Disparities in diagnoses of HIV infection between Blacks/African Americans and other racial/ethnic populations - 37 states, 2005-2008. MMWR 2011, 60(4):93-98.
57. Lansky A., Abdul-Quader A.S., Melissa C., Hall T., Finlayson T.J., Garfein R.S., et al. Developing an HIV behavioral surveillance system for injecting drug users: The National HIV Behavioral Surveillance System. Public Health Reports 2007, 122(Suppl. 1):48-55.
58. Lansky A., Finlayson T., Johnson C., Holtzman D., Wejnert C., Mitsch A., et al. Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLOS ONE 2014, 9(5):e97596. (Electronic resource).
59. Laveist T., Pollack K., Thorpe R., Fesahazion R., Gaskin D. Place, not race: Disparities dissipate in southwest Baltimore when blacks and whites live under similar conditions. Health Affairs 2011, 30(10):1880-1887.
60. Linton S.L., Celentano D.D., Kirk G.D., Mehta S.H. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug and Alcohol Dependence 2013, 132(3):457-465.
61. Logan J.R., Stults B. The persistence of segregation in the metropolis: New findings from the 2010 census 2011, Brown University, Providence, Rhode Island.
62. Luo W., Wang F. Measures of spatial accessibility to health care in a GIS environment: Synthesis and a case study in the Chicago region. Environment and Planning B: Planning and Design 2003, 30:865-884.
63. Massey D.S., Denton N.A. American apartheid: Segregation and the making of the underclass 1993, Harvard University Press, Cambridge, MA.
64. Massey D.S., Bitterman B. Explaining the paradox of Puerto Rican segregation. Social Forces 1985, 64(2):306-331.
65. Massey D.S., Denton N.A. Hypersegregation in U.S. metropolitan areas: Black and Hispanic segregation along five dimensions. Demography 1989, 26(3):373-391.
66. Mauer M. Changing racial dynamics of the war on drugs 2009, The Sentencing Project, Washington, DC.
67. McKnight C., Des Jarlais C., Perlis T., Eigo K., Krim M., Auerbach J., et al. Update: Syringe exchange programs - United States, 2002. Morbidity and Mortality Weekly Report 2005, 54(27):673-676.
68. Milloy M.J., Marshall B.D., Kerr T., Buxton J., Rhodes T., Montaner J., et al. Social and structural factors associated with HIV disease progression among illicit drug users: A systematic review. AIDS 2012, 26(9):1049-1063.
69. Montoya I., Bell D., Richard A., Carlson J., Trevino R. Estimated HIV risk among hispanics in a national sample of drug users. JAIDS 1999, 21(1):42-50.
70. National Institute on Drug Abuse of the National Institutes of Health NIH health disparities strategic plan, fiscal years 2009-2013, National Institute on Drug Abuse 2009, NIH, Bethesda, MD.
71. National Minority AIDS Council African Americans, health disparities, and HIV/AIDS: Recommendations for confronting the epidemic in Black America 2006, National Minority AIDS Council, Washington, DC.
72. Office of Applied Studies in the Substance Abuse and Mental Health Services Administration National directory of drug and alcohol abuse treatment programs 2010 2010, SAMHSA, Bethesda, MD.
73. Office of Disease Prevention and Health Promotion in the U.S.Department of Health and Human Services Healthy people 2020 2012, Department of Health and Human Services, Washington, DC.
74. Office of Management and Budget Revised delineations of metropolitan statistical areas, micropolitan statistical areas, and combined statistical areas, and guidance on uses of the delineations of these areas 2013, Office of Management and Budget, Washington, DC.
75. Ostir G.V., Eschbach K., Markides K.S., Goodwin J.S. Neighbourhood composition and depressive symptoms among older Mexican Americans. Journal of Epidemiology & Community Health 2003, 57(12):987-992.
76. Patel K.V., Eschbach K., Rudkin L.L., Peek M.K., Markides K.S. Neighborhood context and self-rated health in older Mexican Americans. Annals of Epidemiology 2003, 13(9):620-628.
77. Quillian L., Campbell M. Beyond black and white: The present and future of multiracial friendship segregation. American Sociological Review 2003, 68(4):540-566.
78. Rhodes T. The 'risk environment': A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002, 13(2):85-94.
79. Rhodes T. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy 2009, 20:193-201.
80. Rhodes T., Mikhailova L., Sarang A., Lowndes C., Rylkov A., Khutorskoy M., et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science & Medicine 2003, 57(1):39-54.
81. Rhodes T., Singer M., Bourgois P., Friedman S.R., Strathdee S.A. The social structural production of HIV risk among injecting drug users. Social Science & Medicine 2005, 61(5):1026-1044.
82. Robinson W.T., Risser J.M., McGoy S., Becker A.B., Rehman H., Jefferson M., et al. Recruiting injection drug users: A three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. Journal of Urban Health 2006, 83(6 Suppl):i29-i38.
83. Schuurman N., Berube M., Crooks V.A. Measuring potential spatial access to primary health care physicians using a modified gravity model. The Canadian Geographer 2010, 54(1):29-45.
84. Semaan S., Des Jarlais D.C., Malinowska-Sempruch K., Kirby A., Sharpe T.T. Human rights and HIV prevention among drug users. Rights-based approaches to public health 2011, 210-220. Springer Publishing Company, New York. E. Beracochea, C. Weinstein, D. Evans (Eds.).
85. Steiner B.D., Argothy V. White addiction: Racial inequality, racial ideology, and the war on drugs. Temple Political & Civil Rights Law 2001, 443-476. (review).
86. Strathdee S.A., Hallett T.B., Bobrova N., Rhodes T., Booth R., Abdool R., et al. HIV and risk environment for injecting drug users: The past, present, and future. Lancet 2010, 376(9737):268-284.
87. The White House Office of National AIDS Policy National HIV/AIDS strategy 2010, The White House Office of National AIDS Policy, Washington, DC.
88. U.S.Office of Management and Budget Provisional guidance on the implementation of the 1997 standards for federal data on race and ethnicity 2000, Office of Management and Budget, Washington, DC.
89. Waitzman N.J., Smith K.R. Phantom of the area: Poverty-area residence and mortality in the United States. American Journal of Public Health 1998, 88:973-976.
90. Wang F. Quantitative methods in applications in GIS 2006, Taylor and Francis, New York.
91. Williams C., Eisenberg M., Becher J., Davis-Vogel A., Fiore D., Metzger D. Racial disparities in HIV prevalence and risk behaviors among injection drug users and members of their risk networks. JAIDS 2013, 63(Suppl. 1):S90-S94.
92. Williams C., Metzger D. Race and distance effects on regular syringe exchange program use and injection risks: A geobehavioral analysis. American Journal of Public Health 2010, 100(6):1068-1074.
93. Williams D.R., Collins C. Racial residential segregation: A fundamental cause of racial disparities in health. Public Health Reports 2001, 116(5):404-416.
94. Zerai A., Banks R. Dehumanizing discourse, anti-drug law, and policy in America: A "crack mother's" nightmare 2002, Ashgate, United Kingdom.